Clinical trial
Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing. A Multicenter, Interventional Non-pharmacological, Randomized, Single-blind Clinical Trial. IMPACT Study
NCT05792332 is registered in ClinicalTrials.gov with Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Integrated Management of Atypical Parkinsonism: A Home-based Patient-Centered Healthcare Delivery Based on Telenursing. A Multicenter, Interventional Non-pharmacological, Randomized, Single-blind Clinical Trial. IMPACT Study
- Lead sponsor
- Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 17, 2023
- Completion date
- June 30, 2026
- Enrollment
- 164 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
atypical parkinsonism, msa - multiple system atrophy, nurse physician relations, nurse-patient relations, psp